Every October, medical coders brace themselves for one of the most critical transitions in the healthcare revenue cycle — the annual ICD-10-CM update. But FY 2026? This one demands extra attention. After a decade in this field, I can confidently say that the fiscal year (FY) 2026 ICD-10-CM update is one of the most comprehensive releases in recent memory — and if you're not already up to speed, you're putting clean claims at serious risk.
Let me walk you through everything: what changed, why it matters, and how you can apply these updates with confidence from October 1, 2025 through September 30, 2026.
The Big Picture: What CMS Released for FY 2026
The Centers for Medicare & Medicaid Services (CMS) and the National Center for Health Statistics (NCHS) released the FY 2026 ICD-10-CM updates effective October 1, 2025. Here's the headline summary:
- 487 new diagnosis codes
- 38 revised codes
- 28 deleted codes
That's nearly double the number of new codes added in FY 2025 — and it touches 16 chapters of the ICD-10-CM classification. The largest concentrations of change land in Chapter 12 (Skin and Subcutaneous Tissue) and Chapter 19 (Injury, Poisoning, and Certain Other Consequences of External Causes), which alone accounts for 213 new codes.
If you want to dive into the raw files, the official CMS ICD-10 page hosts the complete FY 2026 tabular order, addenda, and code tables. Bookmark it — you'll need it.
Now, let's go chapter by chapter through the high-impact updates.
Chapter 1: Infectious and Parasitic Diseases (A00–B99)
Demodex Mite Infestation — Finally Coded!
Two new codes for acariasis (B88.0-) now capture Demodex mite infestation, including the commonly overlooked Demodex dermatitis and chigger bites. This is bigger than it sounds. Demodex mites cause over 70% of all blepharitis cases, yet until FY 2026, we had no precise ICD-10-CM code to capture this etiology. Now we do.
Why it matters: Dermatology and ophthalmology coders need to train their documentation teams to identify and record Demodex-specific findings at the encounter level so the new codes assign correctly.
HIV Coding — Major Guideline Overhaul
This is the chapter with the most extensive guideline changes. One entirely new HIV guideline was added, and eight existing guidelines were revised with reorganized numbering. The core shift:
- Testing language changes from "If a patient is being seen to determine his/her HIV status" to "If a patient without signs or symptoms is tested for HIV" — a subtle but legally meaningful distinction.
- For patients on antiretroviral medication with no additional documentation of HIV disease, assign Z21 (Asymptomatic HIV infection status), not B20.
- The updated guideline at I.C.1.a.2(j) provides clarified instructions: when documentation shows HIV-positive status but no active HIV disease, Z21 applies "in the absence of any additional documentation of HIV disease, HIV-related illness or AIDS."
HIV coding errors are among the most audited in the country. Get this one wrong and you're looking at compliance exposure, not just a denial. For a deeper dive into documentation best practices that support accurate coding, visit MedCodexHealth.
Chapter 4: Endocrine, Nutritional and Metabolic Diseases (E00–E89)
E11.A — The Game-Changer Code of FY 2026
If there's one code that will define the FY 2026 update in coding conversations for years to come, it's E11.A: Type 2 diabetes mellitus without complications, in remission.
Type 2 diabetes can now officially be documented as being in remission when a patient sustains normal blood glucose levels — typically an A1C below 6.5% — for three months or more without medication. With the rise of GLP-1 receptor agonists like semaglutide, we're seeing remission become a realistic clinical outcome for more patients, making this code immediately relevant.
New guideline I.C.4.a.1(b) instructs coders to assign E11.A only when the provider's documentation explicitly states that diabetes mellitus is in remission. Provider education is essential here — without that documentation, this code cannot be used.
Coding tip: E11.A carries a new Excludes1 note preventing it from being reported simultaneously with E11.9 (Type 2 diabetes mellitus without complications). Do not double-code.
This chapter also adds 23 new codes total, covering hyperoxaluria (a rare genetic disorder with healthcare costs 2.87 times higher than matched controls), lipodystrophy, and other metabolic disorders.
Chapter 6: Diseases of the Nervous System (G00–G99)
Ten new codes expand neurological specificity in ways that matter enormously to neurology and inpatient facility coders:
- Multiple Sclerosis phenotypes: Category G35 expands to allow reporting of specific MS subtypes — relapsing-remitting, primary progressive, and secondary progressive forms. This directly supports disease progression tracking and supports value-based care models.
- Primary progressive apraxia of speech receives its own code, distinguishing it from other speech disorders.
- Muscular dystrophy variants receive new specificity codes, critical for rare disease registries and genetic counseling documentation.
Eight new codes for MS phenotypes alone represent a significant win for neurology practices and CDI programs that track chronic disease trajectories.
Chapter 7: Diseases of the Eye and Adnexa (H00–H59)
Seventeen new codes land in ophthalmology, with some you'll use immediately:
- Demodex blepharitis — now tied directly to the new B88.0- codes in Chapter 1, reinforcing the need to document the underlying mite infestation alongside the eyelid condition.
- Thyroid orbitopathy (H05.831): Expanded to specify laterality (right, left, bilateral). Thyroid eye disease is surging in prevalence, especially among patients on certain immunomodulatory therapies.
- Neovascular secondary angle closure glaucoma (H40.84): Laterality now captured.
- Eyelid inflammation codes under H01.8 expand to specify right/left, upper/lower eyelid — granularity that benefits billing for targeted ophthalmic procedures.
Ophthalmology practices: update your encounter forms and superbills immediately to capture laterality on thyroid eye disease and glaucoma documentation.
Chapter 12: Diseases of the Skin and Subcutaneous Tissue (L00–L99)
112+ New Non-Pressure Chronic Ulcer Codes — The Largest Single-Chapter Expansion
Chapter 12 receives 116 new codes, of which 112 are for non-pressure chronic ulcers — the single largest addition to any chapter in FY 2026. This is where I want coders to slow down and get it right.
The new code structure adds a subcategory L98.A for non-pressure chronic ulcer of the upper limb, with lateral and severity breakdown:
- 6th character identifies depth/severity (breakdown of skin, fat layer exposed, necrosis of muscle, necrosis of bone, muscle involvement without necrosis, bone involvement without necrosis, unspecified severity)
- 7th character captures laterality (right, left, unspecified)
This new framework mirrors the existing lower-extremity ulcer coding structure, bringing long-overdue anatomical specificity to upper limb wound management.
Why this matters for your claims: Non-pressure chronic ulcers are frequently seen in diabetic wound care, vascular surgery, and long-term care settings. Accurate staging and laterality documentation directly affects DRG assignment and risk-adjustment accuracy for chronic care patients.
Documentation reminder: Work with your wound care team to ensure documentation captures the anatomical site AND depth at every encounter. "Non-pressure ulcer, right upper arm with fat layer exposed" codes to a very different level of complexity than a vague wound note.
Chapter 14: Diseases of the Genitourinary System (N00–N99)
Five new codes specifically target APOL1-Mediated Kidney Disease (AMKD) — a hereditary nephropathy predominantly affecting patients of African ancestry. These codes capture:
- Specific forms of IC-MPGN (Immune complex membranoproliferative glomerulonephritis)
- APOL1-related genetic susceptibility (with corresponding Z codes in Chapter 21 for family history)
This addition reflects growing recognition of genetic risk factors in nephrology and is particularly significant for practices participating in kidney disease quality programs.
Chapter 17: Congenital Malformations and Chromosomal Abnormalities (Q00–Q99)
New Category QA0: Genetic Disorders, Not Elsewhere Classified
This is a landmark structural addition. A brand-new category, QA0, captures:
- Neurodevelopmental disorders related to pathogenic variants in specific genes (QA0.01-)
- Other neurodevelopmental disorders related to pathogenic variants (QA0.8)
Additionally, 23 new codes add granularity for syndromes including Hao-Fountain Syndrome, CTNNB1 Syndrome, Kabuki Syndrome, and Usher Syndrome (now coded by type).
Pediatric coding teams and genetics practices need to watch this space carefully. These codes support precision medicine documentation, rare disease registries, and payer prior authorization workflows.
Chapter 18: Symptoms, Signs and Abnormal Findings (R00–R99)
Flank Pain Gets the Specificity It Deserves
Twenty-one new codes arrive in Chapter 18, with 18 specifically targeting flank pain and tenderness. New codes R10.8A- and R10.A- now allow anatomical specification of flank-localized pain — distinguishing "lateral abdominal pain," "lateral flank pain," and "latus region pain" — terminology that previously lumped into general abdominal pain codes.
For emergency medicine, urology, and radiology coders, this is a practical win. Flank pain is a primary ED presentation for kidney stones, and the new specificity supports more accurate documentation trails for clinical workups.
Also new in Chapter 18: A specific code for cannabis hyperemesis syndrome and updated codes for abnormal rheumatoid factor (R76.81).
Chapter 19: Injury, Poisoning and External Causes (S00–T88)
213 new codes. This chapter undergoes the most sweeping numerical expansion in FY 2026.
Key additions include:
- Flank wound specificity: New codes under S31.- capture open wounds of the abdominal wall by specific anatomical site — right flank, left flank — with and without peritoneal penetration. This level of detail matters for trauma surgery, ED coding, and surgical DRG assignment.
- Fluoroquinolone antibiotic toxicity: A new subcategory captures poisoning, adverse effects, and underdosing of fluoroquinolone antibiotics (think ciprofloxacin, levofloxacin) — clinically significant given the growing awareness of fluoroquinolone-associated disability (FQAD).
- Xylazine toxic skin injuries: New codes capture the skin effects of xylazine (an animal tranquilizer increasingly found in the illicit drug supply), mapping both the toxic agent and the wound site.
- Gulf War illness: New codes T75.830- and Z77.31 capture Gulf War illness and exposure to Gulf War theater — long-overdue recognition for veteran healthcare documentation.
- Food allergy refinement: Anaphylaxis and adverse reaction codes for milk/dairy and eggs expand to specify whether the patient reacts to or tolerates baked forms — a clinically meaningful distinction for allergist and pediatric coders.
- Fracture code revision: The term "wrist" has been removed from certain fracture subcategories at S62.9, affecting how coders select codes for wrist and hand fractures. Review your AHA Coding Clinics guidance carefully on this.
Chapter 21: Factors Influencing Health Status (Z Codes)
The Z code expansion in FY 2026 addresses social determinants of health (SDOH), genetic susceptibility, and prophylactic care:
- New codes capture utility insecurity, food instability, housing instability, and adverse environmental exposures — reflecting the national push to capture SDOH in the medical record.
- Z91.B: Personal risk factor of exposure to diethylstilbestrol (DES) — relevant for patients born to mothers who received DES during pregnancy.
- New genetic susceptibility codes for malignancy of fallopian tubes, urinary tract, and digestive system (including colorectal cancer).
- Prophylactic surgery encounter codes (Z40.0-) now have explicit guidance: when a patient undergoes prophylactic organ removal (e.g., bilateral mastectomy due to BRCA status), assign the Z40.0- code as principal or first-listed diagnosis.
Guideline Updates Every Coder Must Know
Beyond the code additions, the FY 2026 ICD-10-CM Official Guidelines for Coding and Reporting received extensive revisions. The ones with the broadest daily impact:
Multiple Sites Coding Guidance: New guidance clarifies that coders should follow chapter-specific guidelines for multiple sites. When no chapter-specific guidance exists, assign codes for the individual sites documented. Assign a "multiple sites" code only when specific sites are not documented.
BMI Fluctuation: When a patient's BMI fluctuates across the reporting period and an encounter addresses a condition where BMI is relevant, assign the code reflecting the most severe BMI value documented.
Neoplasm Therapy Sequencing: Explicit direction states that when the primary purpose of an encounter is chemotherapy, immunotherapy, or external beam radiation therapy to treat a neoplasm, the Z51.- encounter code is the first-listed diagnosis. No ambiguity, no sequencing guesswork.
Common Coding Errors to Watch For in FY 2026
After years in this field, I've seen the same patterns play out every time a major update drops. Avoid these traps:
1. Assigning E11.A without provider documentation. The diabetes remission code requires explicit provider documentation. "A1C within normal range" is not equivalent to a documented remission status.
2. Using deleted codes. Twenty-eight codes were deleted. H01.8 (Other specified inflammations of eyelid) expands into nine new codes — you cannot continue using the parent code for billable encounters. R10.2 (Pelvic and perineal pain) is replaced by six specific codes.
3. Missing laterality on new eye codes. Thyroid orbitopathy and neovascular glaucoma codes now require laterality. Claims without it will deny.
4. Ignoring Excludes1 changes. Several Excludes1 notes have been converted to Excludes2 in FY 2026. The COPD-related changes under J44 are particularly important — what was previously excluded can now be coded as an additional condition.
5. Sequencing HIV codes incorrectly. With the revised HIV guidelines, a single sequencing error can shift a claim from Z21 to B20 — a clinically and financially significant difference.
How to Prepare Your Coding Practice
Whether you work in a hospital, physician practice, outpatient clinic, or remotely as an independent coder, here's your FY 2026 action checklist:
Review code changes relevant to your specialty first, then expand outward. Don't try to memorize 487 codes — understand the logic and the documentation requirements behind the high-volume ones.
Update EHR templates and superbills to capture new specificity fields — laterality, severity, remission status, flank/anatomical site designation.
Educate providers now. The best code in the world means nothing without supporting documentation. Physicians need to know about E11.A, MS phenotype distinctions, thyroid eye disease laterality, and wound depth documentation.
Audit your top 10 denial codes against FY 2026 changes. Many chronic condition codes in Chapter 4 and wound codes in Chapter 12 will affect your risk-adjustment accuracy and DRG assignment.
Verify your EHR and billing software has implemented the October 1, 2025 code set. Missing even a single code in your master file can trigger systematic claim errors.
Why Coding Accuracy Matters More Than Ever in 2026
The healthcare reimbursement landscape is tightening. Value-based care contracts, payer audits, and Risk Adjustment Factor (RAF) calculations all depend on the specificity and completeness of your ICD-10-CM codes. The FY 2026 update wasn't designed to make your job harder — it was designed to make the clinical picture more accurate.
Every new code added in FY 2026 reflects a real clinical condition that was previously being undercoded, miscoded, or lumped into a non-specific category. Demodex blepharitis was real before B88.0- existed — it just wasn't documentable with precision. Type 2 diabetes remission was real before E11.A — it just wasn't codeable. Now it is.
The coders who thrive in this environment are the ones who embrace specificity, stay current with guidelines, and build strong documentation partnerships with their clinical teams.
Key External Resources
- CMS ICD-10-CM FY 2026 Official Guidelines (PDF) — The authoritative source. Read the chapters relevant to your specialty.
- AAPC Knowledge Center — FY 2026 Guideline Update — Practical coding breakdowns for everyday coders.
- ICD10Data.com FY 2026 New Codes — Searchable database of all new, revised, and deleted FY 2026 codes.
- AHA Coding Clinic — Official guidance on code application for complex or ambiguous scenarios.
- AHIMA Body of Knowledge — Continuing education, certification guidance, and coding resources.
Stay Current with MedCodexHealth
Medical coding is not a static profession — it's a dynamic, ever-evolving discipline that demands continuous learning. The FY 2026 ICD-10-CM update is your reminder that accuracy isn't optional; it's the foundation of compliant, optimized revenue cycle management.
For ongoing coding guidance, specialty-specific tips, documentation strategies, and the latest CMS updates, explore the resources at MedCodexHealth. Whether you're a newly certified coder or a ten-year veteran like me, there's always something new to sharpen.
Code accurately. Document completely. Stay compliant.
Disclaimer: This blog post is intended for educational purposes and reflects the FY 2026 ICD-10-CM code set effective October 1, 2025. Always refer to the official CMS ICD-10-CM guidelines and consult appropriate coding resources for specific patient encounters. This content does not constitute legal or billing advice.